Stockscreener 앱 받기
12.84
0.00%
0.00
시간 외 거래:
12.89
0.05
+0.39%
전일 마감가:
$12.84
열려 있는:
$12.84
하루 거래량:
1.27M
Relative Volume:
0.64
시가총액:
$3.20B
수익:
$496.43M
순이익/손실:
$71.35M
주가수익비율:
45.07
EPS:
0.2849
순현금흐름:
$151.57M
1주 성능:
-7.02%
1개월 성능:
+0.78%
6개월 성능:
-31.77%
1년 성능:
-20.94%
1일 변동 폭
$12.41
$12.90
1주일 범위
$12.41
$13.90
52주 변동 폭
$11.02
$19.98
셀러브라이트 Stock (CLBT) Company Profile
Compare CLBT vs MSFT, ORCL, PLTR, CRWD, FTNT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CLBT
Cellebrite Di Ltd
|
12.84 | 3.20B | 496.43M | 71.35M | 151.57M | 0.2849 |
MSFT
Microsoft Corp
|
390.74 | 2.90T | 318.27B | 125.22B | 72.92B | 16.79 |
ORCL
Oracle Corp
|
184.13 | 529.57B | 64.08B | 16.40B | -24.74B | 5.5698 |
PLTR
Palantir Technologies Inc
|
127.99 | 306.83B | 5.22B | 2.29B | 2.69B | 0.8876 |
CRWD
Crowdstrike Holdings Inc
|
682.80 | 173.82B | 5.09B | -24.89M | 1.43B | -0.1885 |
FTNT
Fortinet Inc
|
146.30 | 107.19B | 7.11B | 1.95B | 2.44B | 2.5883 |
셀러브라이트 Stock (CLBT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-03-28 | 재확인 | Needham | Buy |
| 2024-03-13 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2024-02-16 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-07-19 | 개시 | Craig Hallum | Buy |
| 2022-08-12 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-08-12 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2022-02-24 | 개시 | JP Morgan | Overweight |
| 2022-02-11 | 개시 | Deutsche Bank | Buy |
| 2021-12-02 | 개시 | BofA Securities | Buy |
| 2021-10-21 | 개시 | Citigroup | Buy |
모두보기
셀러브라이트 주식(CLBT)의 최신 뉴스
Cellebrite: Stronger Fundamentals Support A Buy Rating (NASDAQ:CLBT) - Seeking Alpha
Cellebrite Genesis: AI-Powered Investigative Solutions - SecurityInformed.com
Cellebrite Genesis: AI investigative tool launch - SourceSecurity.com
Cellebrite DI Ltd. (CLBT) Latest Stock News & Headlines - Yahoo Finance
CLBT: AI-powered tools now deliver rapid, multi-source investigative insights, transforming case workflows - TradingView
Cellebrite launches AI investigation tool Genesis By Investing.com - Investing.com
Cellebrite Di Ltd. Announces General Availability of Genesis - marketscreener.com
Cellebrite Announces Upcoming Investor Events on June 10, 2026 - PR Newswire
Cellebrite DI Ltd stock (IL0011384071): Focus on digital intelligence growth after recent earnings - AD HOC NEWS
Cellebrite receives FedRAMP High Authorization for cloud platform - Investing.com
[PRNewswire] Cellebrite Announces Upcoming Investor Events - Yonhap News Agency
3 Growth Stocks Worth $5,000 of Your Money -- Even in This Market - The Motley Fool
TD Cowen reiterates Buy rating on Cellebrite stock at $23 target By Investing.com - Investing.com South Africa
TD Cowen reiterates Buy rating on Cellebrite stock at $23 target - Investing.com Australia
Tracking How the Cellebrite (CLBT) Investment Narrative Is Evolving Without New Analyst Targets - Yahoo Finance
CLBT News | CELLEBRITE DI LTD (NASDAQ:CLBT) - ChartMill
Cellebrite DI Ltd. Hits Day High with 11.59% Surge in Stock Price - MarketsMojo
Cellebrite DI Ltd. Hits Day High with 7.74% Surge in Stock Price - Markets Mojo
Cellebrite DI (CLBT) Is Up 20.4% After FedRAMP Win And AI Launch MomentumHas The Bull Case Changed? - simplywall.st
126,264-share resale planned for CLBT (NASDAQ: CLBT) via Morgan Stanley - Stock Titan
Why is Cellebrite DI stock rallying 6% today? By Investing.com - Investing.com South Africa
Is It Time To Reassess Cellebrite DI (CLBT) After The Recent Share Price Rebound? - simplywall.st
Why is Cellebrite stock surging 8% today? By Investing.com - Investing.com Australia
CLBT: Upcoming Virtual Meeting Announced for June 4 - GuruFocus
A Look At Cellebrite DI (NasdaqGS:CLBT) Valuation As AI And FedRAMP Cloud Momentum Build - simplywall.st
Cellebrite DI Ltd. (CLBTW) Stock Price, News, Quote & History - Yahoo Finance
Cellebrite DI Eyes AI, Cloud and FedRAMP as Digital Investigations Demand Grows - MarketBeat
TD Cowen Maintains Cellebrite(CLBT.US) With Buy Rating, Maintains Target Price $23 - Moomoo
D.A. Davidson Maintains Cellebrite(CLBT.US) With Buy Rating, Maintains Target Price $20 - Moomoo
DA Davidson initiates coverage of Cellebrite DI (CLBT) with buy recommendation - MSN
D.A. Davidson Initiates Cellebrite(CLBT.US) With Buy Rating, Announces Target Price $20 - Moomoo
Cellebrite (CLBT) CMO sells 5,673 RSU shares under 10b5-1 trading plan - Stock Titan
Is There Now An Opportunity In Cellebrite DI Ltd. (NASDAQ:CLBT)? - Moomoo
CGNT vs. CLBT: Which Intelligence Software Stock Offers Better Upside? - Yahoo Finance
Operating cash flow per share of Cellebrite DI Ltd. – DUS:9W9 - TradingView
A Look At Cellebrite DI (CLBT) Valuation After Q1 2026 Earnings And New Growth Guidance - simplywall.st
Insider sale of 3,064 restricted shares (CLBT) reported to SEC - Stock Titan
5,673 RSUs to be sold by Cellebrite (NASDAQ: CLBT) after S-8 vesting - Stock Titan
CLBT - Intellectia AI
Is the DoD's CMMC Enforcement a Gold Rush for Cybersecurity Providers - Kavout
Earnings call transcript: Cellebrite Q1 2026 beats forecasts, stock rises By Investing.com - Investing.com Australia
BROWN CAPITAL MANAGEMENT LLC's Cellebrite DI Ltd(CLBT) Holding History - GuruFocus
Cellebrite (CLBT) CRO Jewell sells 12,658 shares tied to RSU tax obligations - Stock Titan
Cellebrite DI Sees Federal Rebound as AI, Defense Tools Fuel New Growth - MarketBeat
Cellebrite DI Ltd. (CLBT) reports 31,728 vested RSUs; affiliate recent sales listed - Stock Titan
셀러브라이트 (CLBT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.62%
0.53%
자본화:
|
볼륨(24시간):